Sunless tanning and tanning accelerators

Sunscreens: Regulations and Commercial Development

Volumn , Issue , 2005, Pages 573-599

  Gonzalez, Anthony D ^a   Kalafsky, Robert E ^a  

^a Avon Products Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85056917689     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (53)

1. Information Resources Inc. IRI InfoScan Review Data of the Total US Market (Food, Drug and Mass Excluding Walmart). Chicago, IL: IRI, 1998-2002.
2. US Patent 6,468,508. Laughlin T. Method, Apparatus, and Composition for Automatically Coating the Human Body and Skin Preconditioning System for Use Therewith. Grapevine, TX: Laughlin Products, Inc.
3. Lavker RM, Kaidbey KH. Redistribution of melanosomal complexes within keratinocytes following UV-A irradiation: a possible mechanism for cutaneous darkening in man. Arch Dermatol Res 1982; 272: 215-228.
4. Duval C, Regnier M, Schmidt R. Distinct melanogenic response of human melanocytes in mono-culture, in co-culture with keratinocytes and in reconstructed epidermis, to UV exposure. Pigment Cell Res 2001; 14: 348-355.
5. Tyrell RM. UV-A (320-380 nm) as an oxidative stress. In: Sies H, eds. Oxidative Stress: Oxidants and Anti Oxidants. New York: Academic Press, 1991: 7-78.
6. Auletta M, Gange W, Tan O, Matzinger E. Effects of cutaneous hypoxia upon erythema and pigment responses to UV-A, UV-B and PUVA (8-MOP + UV-A) in human skin. J Invest Dermatol 1986; 86: 649-652.
7. Kochevar IE. Acute effects of ultraviolet radiation on skin. In: Holick MF, Kligman AM, eds. Biological Effects of Light. Berlin: Walter de Gruyter, 1992: 3-10.
8. Swope VB, Abdel-Malek Z, Kassem LM, Nordlund JJ. Interleukins 1-α and 6 and tumor necrosis factor α are paracrine inhibitors of human melanocytes proliferation and melanogenesis. J Invest Dermatol 1991; 96: 180-185.
9. Aberdam A, Auberger P, Ortone JP, Ballotti R. Neprilysin, a novel target for ultraviolet B regulation of melanogenesis via melanocortins. J Invest Dermatol 2000; 115: 381-387.
10. McGregor JM, Hawk JLM. Acute effects of ultraviolet radiation on the skin. In: Freeberg IM, Eisen AZ, et al., eds. Dermatology in Medicine. New York: McGraw-Hill, 1999: 1555-1561.
11. Seite S, Moyal D, Verdier MP, Hourseau C, Fourtanier A. Accumulated p53 protein and UV-A protection level of sunscreens. Photodermatol Photoimmunol Photomed 2000; 16: 3-9.
12. Hemesath TJ, Steingrimsson E, McGill G, Hansen MJ, Vaught J, Hodgkinson CA, Arnheiter H, Copeland NG, Jenkins NA, Fisher DE. Microphthalmia, a critical factor in melanocyte development, defines a discrete transcription factor family. Genes Dev 1994; 8: 2770-2780.
13. Nylander K, Bourdon JC, Bray S, Gibbs NK, Kay R, Hart I, Hall P. Transcriptional activation of tyrosinase by p53 links UV irradiation to the protective tanning response. J Pathol 2000; 190: 39-46.
14. Eller M, Gilchrest B. Tannin as part of the eukaryotic SOS response. Pigment Cell Res 2000; 13: 94-97.
15. Eller MS, Gasparro FP, Amato PE, Gilchrest BA. Induction of melanogenesis by DHA oligonucleotides: effects of oligo size and sequence. J Invest Dermatol 1998; 110: 474.
16. Prota G. Recent advances in the chemistry of melanogenesis in mammals. J Invest Dermatol 1980; 75: 122-127.
17. Nicolaus RA. Link 2-melanin 84. www.tightrope.it/nicolaus/melanin85.htm, 2001: 10.
18. Busca R, Ballotti R. Cyclic AMP a key messenger in the regulation of skin pigmentation. Pigment Cell Res 2000; 13: 60-69.
19. Sakai M, Horikoshi T, Uchiwa H, Miyachi Y. Up-regulation of tyrosinase gene by nitric oxide in human melanocytes. Pigment Cell Res 2000; 13: 248-252.
20. Khaled M, Larribere L, Bille K, Aberdam E, Ortonne JP, Ballotti R, Bertolotto C. Glycogen synthase kinas 3β is activated by cAMP and plays an active role in the regulation of melanogenesis. J Biol Chem 2002; 227: 33690-33697.
21. Lin CB, Barbiarz L, Liebel F, Price ER, Kizoulis M, Gendimenico GJ, Fisher DE, Seiberg M. Modulation of mircophthalmia-associated transcription factor gene expression alters skin pigmentation. J Invest Dermatol 2002; 119: 1330-1340.
22. United States Code of Federal Regulations. 21CFR740.19, 2003.
23. Yoon TJ, Lei TC, Yamaguchi Y, Batzer J, Wolber R, Hearing V. Reconstituted 3-dimensionsl human skin of various ethnic origins as an in vitro model for studies of pigmentation. Anal Biochem 2003; 318: 260-269.
24. Oka M, Nagai H, Ando H, Fukunaga M, Matsumura M, Araki K, Ogawa W, Miki T, Sakaue M, Tsukamoto K, Konishi H, Kikkawa U, Ichihashi M. Regulation of melanogenesis through phosphatidylinositol 3-kinase akt pathway in human G361 melanoma cells. J Invest Dermatol 2000; 115: 699-703.
25. Klejman A, Rushen L, Morrione A, Slupianke A, Skorski T. Phosphatidylinositol-3 kinase inhibitors enhance the anti-leukemia effect of STI571. Oncogene 2002; 21(38): 5868-5876.
26. 2 receptors in human normal melanocytes. J Invest Dermatol 2000; 114(2): 334-341.
27. Prince S, Wiggins T, Hulley PA, Kidson SH. Stimulation of melanogenesis by tetradecanoylphorbol 13-1cetate (TPA) in mouse melanocytes and neural crest cells. Pigment Cell Res 2003; 16: 26-34.
28. Kosano H, Kayanuma T, Nishigori H. Stimulation of melanogenesis in murine melanoma cells by 2-mercapto-1-(β-4-pyridethyl) benzimidazole (MPB). Biochim Biophys 2000; 1499: 11-18.
29. Hachiya A, Kobayashi T, Takema Y, Imokawa G. Biochemical characterization of endothelin-converting enzyme 1-α in cultured skin-derived cells and its postulated role in the stimulation of melanogenesis in human epidermis. J Biol Chem 2002; 277(7): 5395-5403.
30. c-src to melanogenesis and development of fluid transport capacity. Prog Retinal Eye Res 2000; 19(6): 669-688.
31. Hadshiew M, Eller M, Gasparro FP, Gilchrest BA. Stimulation of melanogenesis by DHA oligonucleotides: effect of size, sequence and 5′ phosphorylation. J Dermatol Sci 2001; 25: 127-138.
32. Palumbo A, Poli A, Cosmo A, d’Ischia M. N-methyl-d-aspartate receptor stimulation activates tyrosinase and promotes melanin synthesis in the ink gland of the cuttlefish Sepia officinalis through the nitric oxide/cGMP signal transduction pathway. J Biol Chem 2000; 275(22): 16885-16890.
33. Mallick S, Mandal SK, Bhadra R. Human placental lipid induces mitogenesis and melanogenesis in B16F10 melanoma cells. J Biosci 2002; 27(3): 243-249.
34. Kauser S, Schallreuter K, Thody AJ, Gummer C, Tobin DJ. Regulation of human epidermal melanocyte biology by β-endorphin. J Invest Dermatol 2003; 120(6): 1073-1080.
35. Jung G, Yang J, Song E, Park J. Stimulation of melanogenesis by glycyrrhizin in B16 melanoma cells. Exp Mol Med 2001; 33(3): 131-135.
36. Soliance ARD. Dihydroxyacetone Technical File. Soliance Pomacle Fr. 1997; 9: 27-42.
37. Bernhauer, Shoeniz. Production of dihydroxyacetone by Acetobacter spp. Physiol Chem 1928; 177: 107.
38. US Patent 2,948,658. Process for Producing Dihydroxyacetone. Westfield, NJ: Green S. Baxter Labs Inc.
39. US Patent 2,949,403. Andreadis J, Miklean S. Dihydroxyacetone Compositions for Tanning the Human Epidermis.
40. United States Code of Federal Regulations. 21CFR70, 2003.
41. United States Code of Federal Regulations. 21CFR73, 2003.
42. United States Code of Federal Regulations. 21CFR74, 2003.
43. Pucetti G, Leblanc RM. A sunscreen-tanning compromise: 3D visualization of the actions of titanium dioxide particles and dihydroxyacetone on human epiderm. Photochem Photobiol 2000; 71(4): 426-430.
44. Schneider G, Sprenger G. Transaldolase B: trapping of Schiff base intermediate between dihydroxyacetone and ε-amino group of active-site lysine residue by borohydride reduction. Methods Enzymol 2002; 354: 197-201.
45. Muizzuddin N, Marenus K, Maes D. Tonality of suntan vs. sunless tanning with dihydroxyacetone. Skin Res Tech 2000; 6: 199-204.
46. Nguyen BC, Kochevar I. Influence of hydration on dihydroxyacetone-induced pigmentation of the stratum corneum. J Invest Dermatol 2003; 120(4): 655-661.
47. Suga Y, Ikejima A, Matsuba S, Ogawa H. Medical Pearl: DHA application for camouflaging segmental vitiligo and piebald lesions. J Am Acad Dermatol 2002; 47: 436-438.
48. Asawanonda P, Oberlender S, Taylor C. The use of dihydroxyacetone for photoprotection in variegate porphyria. Int J Dermatol 1999; 38: 916-925.
49. Taylor CR, Kwangsukstith C, Wimberly J, Kollias N, Anderson R. Turbo-PUVA: dihydroxyacetone-enhanced photochemotherapy for psoriasis. Arch Dermatol 1999; 135: 540-544.
50. Rona EM Industries. Dihydroxyacetone. New York: EMD Chemical Hawthorne, 1995; 1: 6-10.
51. Forest S, Grothaus J, Ertel K, Rader C, Plante J. Fluorescence spectral imaging of dihydroxyacetone on skin in vivo. Photochem Photobiol 2003; 77(5): 524-530.
52. Uchida K, Khor T, Oya T, Osawa T, Yasuda Y, Miyata T. Protein modification by a Maillard reaction intermediate methylglyoxal immunochemical detection of fluorescent 5-methylimidazolone derivatives in vivo. FEBS Lett 1997; 410: 313-318.
53. US Patent 6,036,969. Golz-Berner K, Zastrow L. Process for Measuring Cosmetic Tanning and Test Kit Thereof. Haarlem, NL: Coty B.V.